Literature DB >> 27402387

[Not Available].

Sebastian Zschaeck1, Michael Baumann2.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27402387     DOI: 10.1007/s00066-016-1017-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  9 in total

1.  [Abscopal responses of local radiotherapy combined with systemic immunotherapy in patients with metastatic solid tumors].

Authors:  Cédric Panje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2016-01       Impact factor: 3.621

2.  Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.

Authors:  Felix Klug; Hridayesh Prakash; Peter E Huber; Tobias Seibel; Noemi Bender; Niels Halama; Christina Pfirschke; Ralf Holger Voss; Carmen Timke; Ludmila Umansky; Kay Klapproth; Knut Schäkel; Natalio Garbi; Dirk Jäger; Jürgen Weitz; Hubertus Schmitz-Winnenthal; Günter J Hämmerling; Philipp Beckhove
Journal:  Cancer Cell       Date:  2013-10-24       Impact factor: 31.743

3.  Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro.

Authors:  Yusuke Kitoh; Masanao Saio; Naoe Gotoh; Naoki Umemura; Kenichi Nonaka; Juncheng Bai; Laura Vizkeleti; Daniel Torocsik; Margit Balazs; Roza Adany; Tsuyoshi Takami
Journal:  Int J Oncol       Date:  2011-03-03       Impact factor: 5.650

4.  [Therapeutic efficacy of pre-operative radiotherapy on breast carcinoma: in special reference to its abscopal effect on metastatic lymph-nodes].

Authors:  K Konoeda
Journal:  Nihon Gan Chiryo Gakkai Shi       Date:  1990-06-20

Review 5.  Antitumor immune responses induced by ionizing irradiation and further immune stimulation.

Authors:  Benjamin Frey; Yvonne Rubner; Lorenz Kulzer; Nina Werthmöller; Eva-Maria Weiss; Rainer Fietkau; Udo S Gaipl
Journal:  Cancer Immunol Immunother       Date:  2013-09-20       Impact factor: 6.968

6.  Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

Authors:  Encouse B Golden; Arpit Chhabra; Abraham Chachoua; Sylvia Adams; Martin Donach; Maria Fenton-Kerimian; Kent Friedman; Fabio Ponzo; James S Babb; Judith Goldberg; Sandra Demaria; Silvia C Formenti
Journal:  Lancet Oncol       Date:  2015-06-18       Impact factor: 41.316

7.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

8.  Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.

Authors:  Michael T Milano; Alan W Katz; Hong Zhang; Paul Okunieff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-13       Impact factor: 7.038

9.  A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients.

Authors:  Meiying Zhang; Yifeng He; Xiangjun Sun; Qing Li; Wenjing Wang; Aimin Zhao; Wen Di
Journal:  J Ovarian Res       Date:  2014-02-08       Impact factor: 4.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.